Drug intelligence / Profile preview

ginkgo biloba + huperzine A

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Ginkgo biloba + huperzine A is a combination dietary supplement composed of two plant-derived compounds: extracts of the leaves of Ginkgo biloba and the alkaloid huperzine A from Huperzia serrata. Both ingredients have independent pharmacological actions relevant to cognitive function enhancement, especially in the aging population. - **Ginkgo biloba** contains flavonoids, terpenoids, and terpene lactones (ginkgolides and bilobalide) that act as antioxidants, support cerebral blood flow, and have neuroprotective effects by inhibiting platelet-activating factor, reducing oxidative stress, balancing multiple neurotransmitter systems (including glutamatergic, dopaminergic, and cholinergic signaling), and protecting neuronal membranes and mitochondria. - **Huperzine A** is a potent, reversible, and selective inhibitor of acetylcholinesterase (AChE), leading to increased acetylcholine levels in synaptic clefts, enhancing cholinergic neurotransmission, and providing neuroprotection. It also antagonizes NMDA receptor activity, inhibits beta-amyloid neurotoxicity, and exerts antioxidative, antiapoptotic, and additional neuroprotective actions. The combination is marketed for mental fitness, alertness, memory, and cognitive performance improvement, primarily targeting age-related memory decline and cognitive impairment[1][2][3].

Brand names
Ginkozin
02

Targets

Acetylcholinesterase

Beyond the preview

Go deeper on ginkgo biloba + huperzine A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ginkgo biloba + huperzine A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call